Abstract
Sudden death is extremely common in patients suffering from cardiovascular diseases. At least one third of those with hypertension and probably about half of those who survive a myocardial infarction or suffer from cardiac failure who die in a clinical trial, die suddenly. Beta-blockers reduce the risk of sudden death in patients with cardiovascular disease, particularly in those who have had a myocardial infarction or heart failure. ACE inhibitors are perhaps less effective. Other cardiovascular drugs have not been shown to reduce the risk of sudden death.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landray, M. Sudden death: ACE inhibitors and beta-blockers. Basic Res Cardiol 95 (Suppl 1), I37–I40 (2000). https://doi.org/10.1007/s003950070007
Issue Date:
DOI: https://doi.org/10.1007/s003950070007